Transmedics Group Inc (NASDAQ: TMDX) is -2.05% lower on its value in year-to-date trading and has touched a low of $55.00 and a high of $177.37 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TMDX stock was last observed hovering at around $60.82 in the last trading session, with the day’s gains setting it 0.25%.
Currently trading at $61.07, the stock is -4.72% and -12.84% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.35 million and changing 0.41% at the moment leaves the stock -48.78% off its SMA200. TMDX registered -27.17% loss for a year compared to 6-month loss of -58.17%. The firm has a 50-day simple moving average (SMA 50) of $70.6279 and a 200-day simple moving average (SMA200) of $119.3879.
The stock witnessed a -2.52% gain in the last 1 month and extending the period to 3 months gives it a -48.53%, and is 6.77% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.53% over the week and 7.00% over the month.
Transmedics Group Inc (TMDX) has around 584 employees, a market worth around $2.05B and $401.09M in sales. Current P/E ratio is 65.43 and Fwd P/E is 41.56. Profit margin for the company is 8.14%. Distance from 52-week low is 11.04% and -65.57% from its 52-week high. The company has generated returns on investments over the last 12 months (4.50%).
with sales reaching $109.49M over the same period.The EPS is expected to grow by 227.30% this year, but quarterly earnings will post 77.76% year-over-year. Quarterly sales are estimated to grow 34.88% in year-over-year returns.
Transmedics Group Inc (TMDX) Top Institutional Holders
491.0 institutions hold shares in Transmedics Group Inc (TMDX), with institutional investors hold 117.05% of the company’s shares. The shares outstanding are 33.56M, and float is at 32.43M with Short Float at 28.23%. Institutions hold 113.28% of the Float.
The top institutional shareholder in the company is FMR LLC with over 4.49 million shares valued at $676.31 million. The investor’s holdings represent 13.7063% of the TMDX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 2.65 million shares valued at $398.47 million to account for 8.0755 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 2.53 million shares representing 7.7118% and valued at over $380.53 million, while DRIEHAUS CAPITAL MANAGEMENT LLC holds 4.5362 of the shares totaling 1.49 million with a market value of $223.83 million.
Transmedics Group Inc (TMDX) Insider Activity
The most recent transaction is an insider sale by Khayal Tamer I, the company’s Chief Commercial Officer. SEC filings show that Khayal Tamer I sold 1,083 shares of the company’s common stock on Jan 07 ’25 at a price of $80.05 per share for a total of $86694.0. Following the sale, the insider now owns 20843.0 shares.
Transmedics Group Inc disclosed in a document filed with the SEC on Dec 02 ’24 that Khayal Tamer I (Chief Commercial Officer) sold a total of 1,084 shares of the company’s common stock. The trade occurred on Dec 02 ’24 and was made at $86.40 per share for $93658.0. Following the transaction, the insider now directly holds 20843.0 shares of the TMDX stock.
Still, SEC filings show that on Nov 11 ’24, Khayal Tamer I (Chief Commercial Officer) disposed off 1,458 shares at an average price of $90.04 for $0.13 million. The insider now directly holds 20,843 shares of Transmedics Group Inc (TMDX).
